Magnetic Resonance Elastography as a Predictor of Insufficient Liver Enhancement on Gadoxetic Acid–Enhanced Hepatocyte-Phase Magnetic Resonance Imaging in Patients With Type C Hepatitis and Child-Pugh Class A Disease
Authors:
- Utaroh MotosugiUMUtaroh Motosugi
- Tomoaki IchikawaTITomoaki Ichikawa
- Ali MuhiAMAli Muhi
- Katsuhiro SanoKSKatsuhiro Sano
- Hiroyuki MorisakaHMHiroyuki Morisaka
- Shintaro IchikawaSIShintaro Ichikawa
- Tsutomu ArakiTATsutomu Araki
- 1 October 2012
- journal article
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 47 (10) , 566-570
Abstract
The aim of this study was to examine liver stiffness value measured by magnetic resonance elastography (MRE) and laboratory test results to find the best method for predicting insufficient liver enhancement on gadoxetic acid-enhanced hepatocyte-phase images. The institutional ethics committee approved this retrospective study with waiver of informed consent. In total, 118 patients with Child-Pugh class A disease and type C hepatitis underwent MRE and gadoxetic acid-enhanced magnetic resonance imaging. During MRE examination, a pneumatic passive driver was used to obtain liver stiffness in kPa. Liver enhancement was assessed using liver-to-spleen contrast ratio (LSR), calculated using signal intensities of the liver and spleen on hepatocyte-phase magnetic resonance images obtained 20 minutes after contrast administration of gadoxetic acid. Insufficient liver enhancement was defined as an LSR lower than 1.5. The following laboratory test results were used as possible predictors of insufficient liver enhancement as well as liver stiffness measured by MRE: albumin, total bilirubin, aspartate aminotransferase, percentage prothrombin time, and platelet count. Correlation coefficients were calculated between LSR and these variables. Logistic analysis was performed to determine independent predictors of insufficient liver enhancement. All possible predictors investigated were significantly correlated with LSR. Logistic regression analysis revealed that MRE was the only variable to predict insufficient liver enhancement, with an odds ratio (95% confidence interval) of 2.03 (1.22-3.85) (P = 0.0138). A cutoff value of greater than 6.4 kPa yielded 95% specificity for predicting insufficient liver enhancement. Gadoxetic acid is not recommended in patients with liver stiffness greater than 6.4 kPa (consistent with severe fibrosis) because of insufficient liver enhancement on hepatocyte-phase images.Keywords
This publication has 29 references indexed in Scilit:
- Imaging Study of Early Hepatocellular Carcinoma: Usefulness of Gadoxetic Acid–enhanced MR ImagingRadiology, 2011
- Gadoxetic acid‐enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteriaJournal of Magnetic Resonance Imaging, 2011
- Diagnosis of colorectal hepatic metastases: Comparison of contrast‐enhanced CT, contrast‐enhanced US, superparamagnetic iron oxide‐enhanced MRI, and gadoxetic acid‐enhanced MRIJournal of Magnetic Resonance Imaging, 2011
- Detection of Small Hepatocellular CarcinomaInvestigative Radiology, 2011
- Cirrhotic Rat Liver: Reference to Transporter Activity and Morphologic Changes in Bile Canaliculi—Gadoxetic Acid–enhanced MR ImagingRadiology, 2010
- Gadoxetic acid‐enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image‐guided tumor therapyJournal of Magnetic Resonance Imaging, 2010
- Distinguishing Hypervascular Pseudolesions of the Liver from Hypervascular Hepatocellular Carcinomas with Gadoxetic Acid–enhanced MR ImagingRadiology, 2010
- Added Value of Gadoxetic Acid–enhanced Hepatobiliary Phase MR Imaging in the Diagnosis of Hepatocellular CarcinomaRadiology, 2010
- Detection and Characterization of Focal Liver LesionsInvestigative Radiology, 2010
- Evaluation of Regional Liver Function by Gadolinium-EOB-DTPA-Enhanced MR ImagingDigestive Diseases and Sciences, 1999